UP!

CTRP $34.93

CTRP target price
34.93
0
0
Ctrip
Type
Public
Traded as NASDAQ: CTRP
NASDAQ-100 Component
Industry Travel agency
Founded 1999 (IPO December 9, 2003)
Headquarters Shanghai, China
Key people
Sun Jie (Jane Sun, CEO
Products accommodation, ticketing, tours
Revenue
  • IncreaseUS$2.9 billion(2016)
Number of employees
30,000
Website www.ctrip.com

Ctrip is a Chinese provider of travel services including accommodation reservation, transportation ticketing, packaged tours and corporate travel management.

Shanghai-based Ctrip was founded by James Liang, Neil Shen, Min Fan, and Qi Ji in 1999. It listed on NASDAQ in 2003 in a Merrill Lynch-led offering, raising US$75 million (4.2 million ADRs at $18 each) and then further appreciated by 86% to close at $33.94 in its first day of trading. Ctrip traded at a peak of $37.35, making it the first company since the November 2000 IPO of Transmeta to double its price in the first day of trading.

In 2006, about 70% of Ctrip's sales came from just four cities in China: Beijing, Guangzhou, Shanghai, and Shenzhen.

In December 2013, Ctrip acquired the American travel company Tours4fun for over $100 million.

In May 2015, The Priceline Group announced it would be investing an additional $250 million in the company.

In November 2016, Ctrip acquired the Scottish travel company Skyscanner and appointed new CEO Jane Jie Sun.

Ctrip enjoyed spectular growth in recent years. In 2015, Ctrip's net revenues were RMB 10.9 billion (USD 1.7 billion), up 48% year-on-year. In 2016, its net revenue grow 76% year-on-year to RMB19.2 billion (USD 2.9 billion).

In 2006, Liang spoke to Bloomberg about the possibility of Ctrip buying travel companies in other Asian markets such as Hong Kong and South Korea. Ctrip already had an agreement with Taiwan-based ezTravel to cooperate in offering air tickets and hotel rooms to mainland Chinese tourists in Taiwan once tourists from the mainland became able to travel to Taiwan. As of November 2011, Ctrip holds an 8.4% stake in NASDAQ-listed Home Inns as well as a minority stake in the privately held BTC-Jianguo Hotels and Resorts. Ctrip also holds a 1.3% stake in the NASDAQ-listed China Lodging (owner of the Hanting brand). On August 6, 2014, Priceline.com, announced that it will invest $500 million in Ctrip.com International Ltd. to broaden the companies’ options in China. Priceline and Ctrip, which have had a commercial partnership since 2012, will increase their cross-promotion of each company’s hotel inventory and other travel services, the companies said today in a statement. As of November 2016, Ctrip owns both Scottish travel site Skyscanner and American-based travel site Tours4fun.

Ctrip is recognized as a proponent of scientific management in using rigorous data analysis in managerial decision making. One example of this is the randomized control trial Ctrip ran on telecommuting. Given the uncertainty over the impact of telecommuting on company profits they decided to rigorously evaluate its impact before making any management decisions. Ctrip conducted an experiment on 242 employees, sponsored by professors at Stanford University and Peking University. The experiment found that employees randomly assigned to work at home for 9 months increased their output by 13.5% versus the office-based control group, and their turnover rates fell by almost 50%. Adding in the savings from cutting office space telecommuting was found to have substantially reduced costs, leading Ctrip to roll this practice out across the firm.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2019 2019-09-09 2.25 -0.13
Q1 2019 2019-05-23 2.93 1.11
Q4 2018 2019-03-05 0.90 -0.31
Q3 2018 2018-11-07 2.88 -0.34
Q2 2018 2018-09-05 1.90 0.57

Ratings

2016-06-21 Reiterated Rating Bank of America Buy $52.00
2016-06-21 Reiterated Rating Bank of America Corp. Buy $52.00
2016-06-17 Reiterated Rating Nomura Buy $49.00
2016-06-17 Reiterated Rating Deutsche Bank Buy $60.00
2016-06-17 Reiterated Rating Piper Jaffray Overweight $50.00
2016-06-17 Reiterated Rating Piper Jaffray Cos. Overweight $50.00
2016-06-17 Reiterated Rating Nomura Holdings Inc. Buy $49.00
2016-06-17 Reiterated Rating Deutsche Bank AG Buy $60.00
2016-06-16 Reiterated Rating Brean Capital Buy to Buy $56.00 to $52.00
2016-06-16 Reiterated Rating Oppenheimer Buy $55.00
2016-06-16 Reiterated Rating Oppenheimer Holdings Inc. Buy $55.00
2016-06-07 Reiterated Rating Brean Capital Buy
2016-06-02 Reiterated Rating Oppenheimer Buy
2016-05-31 Reiterated Rating Brean Capital Buy
2016-05-24 Reiterated Rating Brean Capital Buy
2016-05-17 Reiterated Rating Brean Capital Buy
2016-04-25 Reiterated Rating Nomura Buy $49.00
2016-04-12 Reiterated Rating Oppenheimer Buy
2016-04-12 Reiterated Rating Brean Capital Buy $56.00
2016-03-17 Lower Price Target Stifel Nicolaus Buy $58.00 to $55.00
2016-03-17 Lower Price Target Brean Capital Buy $65.00 to $56.00
2016-02-23 Initiated Coverage JPMorgan Chase & Co. Overweight $50.00
2016-02-18 Upgrade Credit Agricole Underperform to Buy
2016-02-18 Upgrade Credit Agricole SA Underperform to Buy
2016-02-16 Reiterated Rating Summit Research Buy $62.50
2016-02-01 Initiated Coverage Singular Research Sell
2016-01-22 Reiterated Rating Stifel Nicolaus Buy
2016-01-22 Initiated Coverage Nomura Buy $50.00
2016-01-20 Lower Price Target Macquarie Outperform $71.00 to $53.00
2016-01-16 Reiterated Rating Oppenheimer Buy
2016-01-14 Lower Price Target Oppenheimer Outperform $65.00 to $60.00
2016-01-13 Lower Price Target Deutsche Bank $55.70
2015-12-07 Downgrade HSBC Buy to Hold $54.00 to $55.00
2015-12-04 Lower Price Target Barclays $62.00
2015-12-04 Lower Price Target Barclays PLC $62.00
2015-12-01 Reiterated Rating Summit Research Buy $125.00
2015-11-25 Downgrade UBS AG Buy to Neutral $59.00
2015-11-20 Boost Price Target Deutsche Bank Buy $42.55 to $55.75
2015-11-20 Boost Price Target Barclays Overweight $60.00 to $62.00
2015-11-19 Boost Price Target Piper Jaffray Overweight $57.50 to $62.50
2015-11-19 Boost Price Target Oppenheimer Outperform $55.00 to $65.00
2015-11-19 Boost Price Target Stifel Nicolaus Buy $52.50 to $62.50
2015-11-19 Lower Price Target Brean Capital Buy $65.00 to $48.00
2015-11-13 Downgrade Raymond James Strong-Buy to Outperform $55.00
2015-11-13 Downgrade Raymond James Financial Inc. Strong-Buy to Outperform $55.00
2015-10-27 Reiterated Rating Oppenheimer Outperform $44.00 to $55.00
2015-10-26 Upgrade Goldman Sachs Neutral to Buy $47.00
2015-10-26 Reiterated Rating Summit Research Buy $61.00
2015-10-26 Reiterated Rating Piper Jaffray Buy
2015-10-26 Upgrade Goldman Sachs Group Inc. Neutral to Buy $47.00
2015-10-12 Reiterated Rating Piper Jaffray Buy
2015-10-07 Upgrade Bank of America Neutral to Buy $46.00
2015-09-21 Reiterated Rating Summit Research Buy
2015-09-17 Reiterated Rating Oppenheimer Outperform $47.50 to $44.00
2015-09-15 Reiterated Rating Summit Research Buy $61.00
2015-09-10 Reiterated Rating Brean Capital Buy
2015-08-28 Upgrade Stifel Nicolaus Hold to Buy $44.00
2015-08-14 Reiterated Rating Piper Jaffray Buy
2015-08-05 Reiterated Rating Summit Research Buy
2015-08-05 Reiterated Rating Oppenheimer Outperform $40.00 to $47.50
2015-08-04 Boost Price Target Deutsche Bank Buy $42.15 to $43.95
2015-08-04 Upgrade Morgan Stanley Equal Weight to Overweight $49.00
2015-08-04 Reiterated Rating Brean Capital Buy $48.00
2015-08-04 Reiterated Rating Piper Jaffray Buy $45.50
2015-07-23 Reiterated Rating Macquarie Buy $50.00
2015-07-14 Reiterated Rating Wunderlich Buy $61.00
2015-07-13 Reiterated Rating Summit Research Buy $61.00
2015-07-10 Reiterated Rating Stifel Nicolaus Hold
2015-07-03 Reiterated Rating Piper Jaffray Overweight $45.50
2015-06-05 Reiterated Rating Summit Research Buy $61.00
2015-06-02 Downgrade Stifel Nicolaus Buy to Hold
2015-05-26 Boost Price Target Summit Research Buy $40.00 to $61.00
2015-05-22 Upgrade Raymond James Market Perform to Strong-Buy $55.50
2015-05-18 Initiated Coverage Guggenheim Buy $45.00
2015-05-18 Upgrade JPMorgan Chase & Co. Neutral to Overweight $31.50 to $43.50
2015-05-16 Reiterated Rating Piper Jaffray Overweight $45.00 to $45.50
2015-05-14 Upgrade Oppenheimer Market Perform to Outperform $40.00
2015-05-14 Reiterated Rating Brean Capital Buy $35.00 to $48.00
2015-05-14 Upgrade Stifel Nicolaus Hold to Buy $40.00 to $44.00
2015-05-14 Reiterated Rating Summit Research Hold
2015-05-14 Upgrade Piper Jaffray Neutral to Outperform $27.00 to $45.00
2015-05-07 Upgrade Barclays Equal Weight to Overweight $30.00 to $41.00
2015-04-20 Initiated Coverage Summit Research Hold $34.00
2015-04-10 Reiterated Rating Brean Capital Buy $35.00
2015-04-07 Upgrade Piper Jaffray Neutral to Overweight $27.00 to $45.00
2015-03-20 Boost Price Target Brean Capital Buy $32.00 to $35.00
2015-03-12 Initiated Coverage Societe Generale Sell
2015-02-12 Downgrade Oppenheimer Outperform to Market Perform
2014-11-28 Downgrade Morgan Stanley Overweight to Equal Weight $37.95 to $28.50
2014-11-28 Downgrade JPMorgan Chase & Co. Overweight to Neutral $41.00 to $28.50
2014-11-28 Reiterated Rating Oppenheimer Outperform $29.00
2014-11-26 Lower Price Target Brean Capital Buy $37.00 to $32.00
2014-11-26 Downgrade Barclays Overweight to Equal Weight
2014-11-26 Lower Price Target Goldman Sachs $29.50
2014-11-26 Downgrade Raymond James Outperform to Market Perform $36.00
2014-11-21 Initiated Coverage HSBC Overweight $38.00
2014-11-20 Reiterated Rating Deutsche Bank Buy $38.50 to $35.00
2014-10-21 Initiated Coverage Citigroup Inc. Buy $35.50
2014-08-07 Reiterated Rating Deutsche Bank Buy $36.50 to $40.00
2014-08-07 Upgrade Credit Agricole Underperform to Buy $39.00
2014-08-01 Downgrade Aegis Buy to Hold $30.00 to $33.00
2014-07-31 Boost Price Target T.H. Capital $36.00
2014-07-31 Reiterated Rating Raymond James Outperform $33.00 to $36.00
2014-07-31 Boost Price Target Brean Capital Buy $30.00 to $37.00
2014-07-31 Boost Price Target Oppenheimer Outperform $26.50 to $37.50
2014-07-29 Boost Price Target Barclays Overweight $26.50 to $39.00
2014-06-30 Boost Price Target Deutsche Bank Buy $29.00 to $37.00
2014-06-25 Downgrade Raymond James Strong-Buy to Outperform
2014-06-24 Downgrade Stifel Nicolaus Buy to Hold $29.00
2014-05-12 Boost Price Target Macquarie $27.50 to $28.00
2014-05-08 Reiterated Rating Morgan Stanley Sell to Overweight $25.25
2014-04-04 Reiterated Rating Aegis Positive
2014-03-13 Initiated Aegis Capital Buy $60
2014-03-13 Initiated Coverage Aegis Buy $30.00
2014-02-13 Lower Price Target Oppenheimer Outperform $32.50 to $25.00
2014-02-13 Upgrade Morgan Stanley Equal Weight to Overweight $27.50 to $25.25
2014-01-14 Upgrade JPMorgan Chase & Co. Neutral to Overweight
2014-01-10 Downgrade Credit Agricole Outperform to Underperform
2013-11-06 Boost Price Target Raymond James Strong-Buy $50.00 to $71.00
2013-11-06 Boost Price Target Oppenheimer Outperform $40.00 to $65.00
2013-11-06 Boost Price Target Brean Capital Buy $55.00 to $78.00
2013-11-06 Boost Price Target T.H. Capital Buy $64.00 to $66.00
2013-10-29 Upgrade T.H. Capital Hold to Buy
2013-10-21 Reiterated Rating Deutsche Bank Buy $65.00
2013-10-21 Boost Price Target Stifel Nicolaus Buy $48.00 to $72.00
2013-09-26 Initiated Coverage Credit Suisse Outperform
2013-09-25 Upgrade Deutsche Bank Hold to Buy $35.20 to $65.00
2013-08-01 Upgrade Stifel Hold to Buy $48
2012-02-21 Downgrade Brean Murray Hold to Sell $19
2011-11-14 Downgrade Brean Murray Buy to Hold
2011-08-04 Upgrade Brean Murray Hold to Buy $43
2011-02-15 Reiterated Oppenheimer Outperform $54 to $50
2011-01-03 Downgrade Stifel Nicolaus Buy to Hold
2010-11-17 Initiated Stifel Nicolaus Buy $60
2010-07-07 Downgrade Brean Murray Buy to Hold
2010-06-24 Initiated Brean Murray Buy $51
2009-08-18 Upgrade Piper Jaffray Neutral to Overweight
2009-08-05 Reiterated Kaufman Bros Buy $50 to $63
2009-08-05 Downgrade Susquehanna Financial Positive to Neutral
2009-05-13 Upgrade Deutsche Securities Hold to Buy
2009-05-12 Upgrade Citigroup Sell to Buy $16 to $40
2009-05-07 Initiated Oppenheimer Outperform $37
2008-11-14 Reiterated Kaufman Bros Hold $47 to $31
2016-06-21 Reiterated Rating Bank of America Buy $52.00
2016-06-21 Reiterated Rating Bank of America Corp. Buy $52.00
2016-06-17 Reiterated Rating Nomura Buy $49.00
2016-06-17 Reiterated Rating Deutsche Bank Buy $60.00
2016-06-17 Reiterated Rating Piper Jaffray Overweight $50.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks